Ivarmacitinib, a novel Janus kinase 1 inhibitor, may be considered a potential treatment for patients with moderate to severe ...

A recent study says gut imbalance can be one of the reasons for painful and debilitating rheumatoid arthritis. The research ...

The management of rheumatoid arthritis has seen tremendous changes over the past 25 years, since the increasing availability of biological disease-modifying antirheumatic drugs (DMARDs) with various ...

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests. Changes in the make-up of the gut ...

Genetic markers may help predict response to TNF inhibitor therapy in rheumatoid arthritis, potentially leading to more ...

A research team from the University of Central Florida's College of Medicine conducted a study of patient perceptions of ...

Postmenopausal women, particularly those who experience early menopause, may have a higher risk for developing rheumatoid ...

AnaptysBio's rosnilimab faces significant competition and uncertainty. See why ANAB stock's future hinges on Feb 2025 Phase ...